
Add high-sensitivity rapid COVID testing to your practice.
Offer accurate PCR-quality COVID testing to your practice and generate more revenue with a lower per-test cost than other molecular tests.
Get PCR-quality results at a fraction of the time & cost.
UOL COVID-19 Test utilizes patented molecular chemistry to provide PCR-quality results within 40 minutes, at a lower cost than other molecular tests. Approved by FDA.
96.1% Accuracy
96.1% Accuracy with no false positives when compared to a highly-sensitive PCR test. Learn more
PCR Sensitivity
NAATs can detect COVID up to 4 days earlier than antigen tests Learn more
Result in 40 minutes
As soon as 12 minutes for positive results.
Negative results in 40 minutes.
5-minute Setup
Anterior nasal swab sample collection, set up and run a test in under 5 minutes.
Powerful Detection
Detect all VOCs including Delta, BA.1, BA.2, BA.4, and BA.5. Analytical sensitivity over 20,000x higher than some commercially-available rapid antigen tests.
Tech Enabled
Our DxPro mobile app automatically interprets data with clear-text results. Patient registration, SMS result delivery, and automated reporting are available*.
*requires additional software integration, contact sales for more info.
-
UOL COVID-19 Test System
-
UOL COVID-19 Instrument
-
UOL COVID-19 Test Kit
-
DxPro App*
Loop-de-Loop™ RT-LAMP
A new test for the new normal.
The UOL COVID-19 Test uses a new, patented chemistry, the Loop-de-Loop™ RT-LAMP. Ideal for detection of infectious disease, with the power of PCR without complex equipment.
The result? Lower costs while maintaining accuracy.

Supported by leading institutions and investors.
Uh-Oh Labs is developing diagnostic tests through our Loop-de-Loop™ platform which enables simplicity, speed, and lower costs while providing accurate, lab-grade results.
We are led by a team of experts in molecular diagnostics and bioengineering and are supported by the National Institute of Health’s Rapid Acceleration of Diagnostics (RADx) initiative and private investors, including Y Combinator.
Accessible testing for all healthcare providers.
New services in pharmacies
Rapid results for primary care
Lower costs at rapid test sites